Today’s news summary – Paper Talk
Monday’s papers are dominated by British teen sensation Emma Raducanu – after her US Open victory, with the paper’s continuing to report on the next steps for the teenager.
The prime minister’s expected announcement that he is to scrap Covid laws that are no longer needed and end the travel traffic light system is a leading front-page story for many of Monday’s papers.
………….
‘Abolishing Covid laws, the PM’s winter plan’
The Daily Telegraph reports the PM will say he is “dead set” against another lockdown when he unveils his winter plan. The paper says it is concerned that different rules in different nations could confuse people and calls for an end to all restrictions.
“Booster jabs or bust” is the i newspaper’s take on the plan the prime minister intends to announce. The paper says he is banking on boosting the immunity of the most vulnerable with a third vaccine dose for millions of older people.
The Sun sees it as a “win for liberty” although the i newspaper suggests that tougher rules may still be imposed if people don’t act cautiously.
The Daily Mail welcomes reports that many Covid restrictions in England will be lifted.
The Times calls it a “risky” U-turn, suggesting voluntary vaccine checks may not be enough.
‘Emma Raducanu could see £150m fortune’
Teen tennis sensation Emma Raducanu features as the main picture on most papers – a day after winning the US Open, the teen is pictured holding up her trophy.
The Daily Mail suggests Emma Raducanu could be in line for an OBE, or even a CBE.
The Times speculates that she might earn £150 million from future sponsorship deals; the Express suggests she could earn a billion dollars.
‘Wonder blood test’
A new blood test that is believed to be able to detect more than 50 cancers before symptoms appear makes the front page of several papers.
The Daily Express welcomes the news of what it calls the “wonder blood test” for cancers that is being trialled by the NHS in England.
“Cancer test revolution,” says the Daily Mirror, the paper suggests it could save thousands of lives and revolutionise treatments. The Independent website says research indicates that the test has a very low false-positive rate.